D-382-2014 Class III Terminated
FDA drug recall D-382-2014 was initiated by Teva Pharmaceuticals USA on Dec 4, 2013 and is designated Class III. Reason for recall: Defective Delivery System: There is a potential for some units in certain lots of Qnasl Nasal Aerosol 80 mcg metered spray to have clogged stem valves. The recall status is terminated (terminated Aug 27, 2014). Affected quantity: 379,463 inhalers.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 1, 2014
- Initiation Date
- Dec 4, 2013
- Termination Date
- Aug 27, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 379,463 inhalers
Product description
Qnasl (beclomethasone dipropionate) Nasal Aerosol, 80 mcg per spray, 120 metered sprays, 8.7 g inhaler, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044; By: 3M Delivery Systems, Northridge, CA 91324, NDC 59310-210-12, UPC 3 59310 21012 9.
Reason for recall
Defective Delivery System: There is a potential for some units in certain lots of Qnasl Nasal Aerosol 80 mcg metered spray to have clogged stem valves.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: 120004, Exp 01/14; 120095, 120131, 120131 2, Exp 03/14; 120271, Exp 07/14; 120351, Exp 08/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-382-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026